Five Drivers Supporting GLP-1 Expansion These are likely to be the key drivers of a further global unlock of GLP-1 utilization, according to Morgan Stanley Research: 1 Oral Treatments GLP-1 oral therapies for weight loss became available in the U.S
After four weeks, the dose is increased to 5 mg weekly, which represents the first maintenance dose for glycemic control
use of systemic corticosteroids within 60 days before screening or intraarticular corticosteroid injection (inhaled or topical steroids were allowed)
Sharing poses a risk for transmission of blood-borne pathogens
Acetaminophen may be familiar, but that doesnt mean it doesnt have side effects
Committed says: I am doing this even when it is not convenient. I am going to follow the plan long enough to let it work. I am done jumping from one program to another. I am ready to make my health, fitness, and wellness a priority. That is where real change starts